Literature DB >> 10216205

Axonal transport is inhibited by a protein kinase C inhibitor in cultured isolated mouse dorsal root ganglion cells.

H Hiruma1, H Maruyama, T Katakura, Z B Simada, S Nishida, S Hoka, T Takenaka, T Kawakami.   

Abstract

We investigated roles of protein kinase C (PKC) and Ca2+/calmodulin-dependent protein II (CAM II) kinase activities in the maintenance of axonal transport in cultured isolated mouse dorsal root ganglion (DRG) cells. Video-enhanced microscopic recordings revealed that the PKC inhibitor chelerythrine (1 microM) reduced anterograde and retrograde axonal transport, while the CAM II kinase inhibitor KN-62 (10 microM) had no effect. Morphological observation showed that neurite growth was prevented by the presence of chelerythrine (1 microM). From these results, we conclude that PKC activity is required to maintain axonal transport and thereby neurite growth. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216205     DOI: 10.1016/s0006-8993(99)01249-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Role of nociceptor αCaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats.

Authors:  Luiz F Ferrari; Oliver Bogen; Jon D Levine
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

2.  Adenylate cyclase regulates elongation of mammalian primary cilia.

Authors:  Young Ou; Yibing Ruan; Min Cheng; Joanna J Moser; Jerome B Rattner; Frans A van der Hoorn
Journal:  Exp Cell Res       Date:  2009-07-02       Impact factor: 3.905

3.  Neuropeptide Y inhibits axonal transport of particles in neurites of cultured adult mouse dorsal root ganglion cells.

Authors:  Hiromi Hiruma; Ayako Saito; Tatsumi Kusakabe; Toshifumi Takenaka; Tadashi Kawakami
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

Review 4.  Post-translational modifications of voltage-gated sodium channels in chronic pain syndromes.

Authors:  Cedric J Laedermann; Hugues Abriel; Isabelle Decosterd
Journal:  Front Pharmacol       Date:  2015-11-05       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.